Bemcentinib Recruiting Phase 1 Trials for Non-Small Cell Lung Carcinoma (NSCLC) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02922777Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.